Terms: = Pancreatic cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
13 results:
1. Small molecular inhibitors for KRAS-mutant cancers.
Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
[TBL] [Abstract] [Full Text] [Related]
2. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract] [Full Text] [Related]
3. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and Can be Targeted to Inhibit Invasiveness in pancreatic cancer Cells.
Liu H; Li X; Dun MD; Faulkner S; Jiang CC; Hondermarck H
Proteomics; 2020 May; 20(10):e1900331. PubMed ID: 32170829
[TBL] [Abstract] [Full Text] [Related]
4. miR-29a Is Repressed by MYC in pancreatic cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
Dey S; Kwon JJ; Liu S; Hodge GA; Taleb S; Zimmers TA; Wan J; Kota J
Mol Cancer Res; 2020 Feb; 18(2):311-323. PubMed ID: 31662451
[TBL] [Abstract] [Full Text] [Related]
5. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better prognosis in Intraductal pancreatic Mucinous Neoplasms.
Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Implications of nras Overexpression in Resectable pancreatic Adenocarcinoma Patients.
Martinez-Useros J; Li W; Georgiev-Hristov T; Fernandez-Aceñero MJ; Borrero-Palacios A; Perez N; Celdran A; Garcia-Foncillas J
Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
[TBL] [Abstract] [Full Text] [Related]
7. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Martinez-Useros J; Georgiev-Hristov T; Fernández-Aceñero MJ; Borrero-Palacios A; Indacochea A; Guerrero S; Li W; Cebrián A; Gómez Del Pulgar T; Puime-Otin A; Del Puerto-Nevado L; Rodríguez-Remírez M; Pérez N; Celdrán A; Gebauer F; Garcia-Foncillas J
PLoS One; 2017; 12(8):e0182044. PubMed ID: 28763470
[TBL] [Abstract] [Full Text] [Related]
8. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.
Mitsuhashi K; Nosho K; Sukawa Y; Matsunaga Y; Ito M; Kurihara H; Kanno S; Igarashi H; Naito T; Adachi Y; Tachibana M; Tanuma T; Maguchi H; Shinohara T; Hasegawa T; Imamura M; Kimura Y; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Oncotarget; 2015 Mar; 6(9):7209-20. PubMed ID: 25797243
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological characteristics and prognostic impact of colorectal cancers with nras mutations.
Ogura T; Kakuta M; Yatsuoka T; Nishimura Y; Sakamoto H; Yamaguchi K; Tanabe M; Tanaka Y; Akagi K
Oncol Rep; 2014 Jul; 32(1):50-6. PubMed ID: 24806883
[TBL] [Abstract] [Full Text] [Related]
10. Papillary cystic tumors of the pancreas: assessment of malignant potential by analysis of progesterone receptor, flow cytometry, and ras oncogene mutation.
Lee WY; Tzeng CC; Chen RM; Tsao CJ; Tseng JY; Jin YT
Anticancer Res; 1997; 17(4A):2587-91. PubMed ID: 9252685
[TBL] [Abstract] [Full Text] [Related]
11. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract] [Full Text] [Related]
12. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
[TBL] [Abstract] [Full Text] [Related]
13. ras and human tumors.
Rodenhuis S
Semin Cancer Biol; 1992 Aug; 3(4):241-7. PubMed ID: 1421168
[TBL] [Abstract] [Full Text] [Related]
